Perhaps the deal will lead to even more consults than I assumed...

First 3 Last

Share
Profile

Follow
rustys33

1,848 Posts.

530

20/03/24

11:47

Post #: 72975028
Share

Originally posted by rustys33: ↑

Appears to be a logical lead generator partnership.

We don't have a lot of figures to go by, but they have stated 7.5 million tests in 24 years. If I assume growth since 2021, then Medicheck could be doing 900,000 tests per annum (average per annum is 300,000 tests). If I assume we can convert 3% of these test to a consult, then this partnership could result in 27,600 consults per annum. At AUD$88 per consult, that's another AUD2.5 million in the kitty each year. A lot of missing information here, but this deal has the potential to be significant in terms of revenue generation ie if Medicheck are doing more tests and the conversion rate could be higher if the customer experience is seamless. The added benefit is the DOC gets exposed to their 200,000 customers.

Good move by the DOC

Modelled Medicheck blood tests

Expand

Perhaps the deal will lead to even more consults than I assumed - albeit 3% seems like a conservative conversion figure now

"Sam Rodgers, a practising GP in southeast London and chief medical officer at Medichecks, points out that people are directed to their GP after its testing in about 7% of cases, while Nightingale said its tests were for “prediction and prevention rather than diagnosis or treatment” and it didn’t provide test results as such but overall risk information and lifestyle guidance. "

https://www.bmj.com/company/newsroom/concern-over-unregulated-high-street-health-checks-that-may-be-putting-extra-pressure-on-the-nhs/

DOC Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply